Gilbert S. Omenn
Board Member
Galectin Therapeutics Inc (GALT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gilbert S. Omenn
Gilbert S. Omenn is recorded as Board Member at Galectin Therapeutics Inc (GALT). Elicio Therapeutics, Inc. reported in an 8-K filed June 2, 2023 that Gilbert S. Omenn resigned as member of Angion's board of directors, effective June 1, 2023.
“each of Victor F. Ganzi, J.D., Itzhak D. Goldberg, M.D. and Gilbert S. Omenn, M.D., Ph.D., resigned from Angion's board of directors and any respective committee membership of Angion's board of directors, effective as of the effective time of Merger”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2014-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Galectin Therapeutics Inc
Other people whose current roles at this company are on record from its filings.
- Joel Lewis CEO, Board Member
- Jack W. Callicutt CFO
- Benjamin S. Carson Board Member
- Dr. Henry Brem Board Member
- Elissa J. Schwartz Board Member
- Gilbert F. Amelio Board Member
- Harold H. Shlevin Board Member
- Henry Brem Board Member
- Kary Eldred Board Member
- Kevin D. Freeman Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.